258 related articles for article (PubMed ID: 18701451)
1. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta.
Smeets PJ; Teunissen BE; Planavila A; de Vogel-van den Bosch H; Willemsen PH; van der Vusse GJ; van Bilsen M
J Biol Chem; 2008 Oct; 283(43):29109-18. PubMed ID: 18701451
[TBL] [Abstract][Full Text] [Related]
2. PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes.
Ding G; Cheng L; Qin Q; Frontin S; Yang Q
J Mol Cell Cardiol; 2006 Jun; 40(6):821-8. PubMed ID: 16698033
[TBL] [Abstract][Full Text] [Related]
3. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
5. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome Proliferator-Activated Receptor
Jen HL; Liu PL; Chen YH; Yin WH; Chen JW; Lin SJ
Mediators Inflamm; 2016; 2016():5609121. PubMed ID: 27807394
[TBL] [Abstract][Full Text] [Related]
8. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
9. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
[TBL] [Abstract][Full Text] [Related]
10. High-fat feeding in cardiomyocyte-restricted PPARdelta knockout mice leads to cardiac overexpression of lipid metabolic genes but fails to rescue cardiac phenotypes.
Li Y; Cheng L; Qin Q; Liu J; Lo WK; Brako LA; Yang Q
J Mol Cell Cardiol; 2009 Oct; 47(4):536-43. PubMed ID: 19595695
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
12. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
[TBL] [Abstract][Full Text] [Related]
13. Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.
Razeghi P; Wang ME; Youker KA; Golfman L; Stepkowski S; Taegtmeyer H
Cardiovasc Res; 2007 Apr; 74(1):133-9. PubMed ID: 17276423
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblasts.
Liang YJ; Chen CY; Juang SJ; Lai LP; Shyu KG; Wang BW; Liu SY; Leu JG
Eur J Pharmacol; 2010 Sep; 643(1):84-92. PubMed ID: 20599914
[TBL] [Abstract][Full Text] [Related]
16. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis.
Zingarelli B; Piraino G; Hake PW; O'Connor M; Denenberg A; Fan H; Cook JA
Am J Pathol; 2010 Oct; 177(4):1834-47. PubMed ID: 20709805
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV Alleviates the Myocardial Damage Induced by Lipopolysaccharide via the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB)/Proliferator-Activated Receptor α (PPARα) Signaling Pathway.
Zhang X; Li M; Wang H
Med Sci Monit; 2019 Sep; 25():7158-7168. PubMed ID: 31545785
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Takano H; Nagai T; Asakawa M; Toyozaki T; Oka T; Komuro I; Saito T; Masuda Y
Circ Res; 2000 Sep; 87(7):596-602. PubMed ID: 11009565
[TBL] [Abstract][Full Text] [Related]
20. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
